These findings were further supported by Ingenuity® Pathway Analysis (data not shown), which also predicted that p21 silencing would affect liver fibrosis via modulation of early signaling pathways in HSCs, mainly by modulation of collagen production and TGF‐β signaling (Appendix Fig S7). The gene discussed is CDKN1A; the disease is Hepatic fibrosis.